NEET MDS Shorts
61670
Oral PathologyThe female breast is most sensitive to radiation-induced cancer.
14754
INI CET
While Coarctation is a major congenital cause, Acute Glomerulonephritis is a very common acquired cause of pediatric hypertension in the Indian clinical setting. However, the provided key emphasizes Coarctation.
75463
Oral PathologyA compound odontoma is a benign odontogenic tumor consisting of enamel, dentin, cementum, and pulp arranged in recognizable tooth-like structures. Radiographically, it appears as multiple small, tooth-like radiopaque structures, unlike complex odontomas, which show as masses of calcified material.
88254
Orthodontics
SOLUTION NSAIDS, i.e. Brufen, etc. inhibit tooth movement as they interfere with production of prostaglandins.
• Nimesulide does not interfere with PG production and so can be safely given during tooth movements.
70754
Prosthodontics
Explanation: The sagittal inclination of the incisal guidance table is set to
match the patient's natural incisor relationship. By bringing the central
incisors into an end-to-end relationship, the articulator can be adjusted to
simulate the patient's individual incisal guidance, which is essential for
accurate jaw movement and occlusion.
97941
Pharmacology
Alkalinization of urine is used in patients receiving high dose methotrexate to promote renal excretion and to avoid nephrotoxicity IV Sodium bicarbonate is used to maintain urine pH above 7.0 to avoid precipitation of methotrexate (a weak acid) in the acid pH of renal tubules
97200
ProsthodonticsNone of the listed conditions allow safe RPD construction without medical consultation. Diastolic pressure >130mmHg indicates severe hypertension, uncontrolled seizures pose safety risks, and uncontrolled arrhythmia requires cardiac evaluation. All these conditions require medical clearance and management before dental treatment can proceed safely.
88750
Oral PathologyReduced salivary flow reaches essentially zero at a dose of 6000 rads.
41039
Biochemistry
The rate limiting step in cholesterol synthesis is HMG CoA reductase. Here's
a detailed explanation:
Cholesterol synthesis is a complex process that involves multiple enzymatic
steps. This process begins with the condensation of acetyl-CoA molecules to form
acetoacetyl-CoA, which is then converted into HMG CoA
(3-hydroxy-3-methylglutaryl-CoA) by the enzyme HMG CoA synthetase. HMG CoA is
further converted to mevalonate by the action of HMG CoA reductase. This
reaction is the rate limiting step of the cholesterol synthesis pathway. The
rate limiting step is the slowest step in a metabolic pathway and is responsible
for controlling the overall rate of the process.
HMG CoA reductase is a critical regulatory enzyme that is tightly controlled
because it is the first committed step in the synthesis of cholesterol from
acetate. This enzyme is responsible for reducing HMG CoA to mevalonate, which is
the precursor of all isoprenoids, including cholesterol, steroids, and other
important biological molecules. The rate limiting nature of this step is due to
the fact that HMG CoA reductase is subject to both allosteric regulation and
feedback inhibition.
Allosteric regulation involves the binding of regulatory molecules, such as ATP,
citrate, and NADH, which can either activate or inhibit the enzyme. For example,
when cellular ATP levels are high, the enzyme is inhibited, which reduces
cholesterol synthesis. Conversely, when ATP levels are low, the enzyme is
activated, leading to increased cholesterol production. Citrate, a molecule
derived from the citric acid cycle, inhibits HMG CoA reductase when it builds up
in the cytosol, indicating that the cell has enough energy and does not need to
synthesize additional cholesterol.
Feedback inhibition occurs when the end product of the pathway, cholesterol,
binds to the enzyme and reduces its activity. This is a form of negative
feedback regulation that helps to maintain homeostasis of cholesterol levels
within the cell. When cellular cholesterol levels are high, the enzyme is
inhibited, which slows down the synthesis of new cholesterol molecules.
Conversely, when cholesterol levels are low, the enzyme is less inhibited, and
the synthesis rate increases.
The other enzymes listed, HMG CoA synthetase and mevalonate synthetase, are
involved in the synthesis of HMG CoA and the subsequent transformation of
mevalonate, but they are not the rate limiting steps. HMG CoA lyase, on the
other hand, is part of an alternative pathway that breaks down HMG CoA into
acetyl-CoA and acetoacetate. This enzyme is not directly involved in the rate
limiting step of cholesterol synthesis.
68341
Dental Materials
Neurological changes are not detected until urine mercury levels exceed 500 µg/L, which is significantly higher than the levels associated with amalgam placement.